OBJECTIVES: The inferior frontal cortical-striatal network plays an integral role in response inhibition in normal populations. While inferior frontal cortex (IFC) impairment has been reported in mania, this study explored whether this dysfunction persists in euthymia. METHODS: Functional magnetic resonance imaging (fMRI) activation was evaluated in 32 euthymic patients with bipolar I disorder and 30 healthy subjects while performing the Go/NoGo response inhibition task. Behavioral data were collected to evaluate accuracy and response time. Within-group and between-group comparisons of activation were conducted using whole-brain analyses to probe significant group differences in neural function. RESULTS: Both groups activated bilateral IFC. However, between-group comparisons showed a significantly reduced activation in this brain region in euthymic patients with bipolar disorder compared to healthy subjects. Other frontal and basal ganglia regions involved in response inhibition were additionally significantly reduced in bipolar disorder patients, in both the medicated and the unmedicated subgroups. No areas of greater activation were observed in bipolar disorder patients versus healthy subjects. CONCLUSIONS: Bipolar disorder patients, even during euthymia, have a persistent reduction in activation of brain regions involved in response inhibition, suggesting that reduced activation in the orbitofrontal cortex and striatum is not solely related to the state of mania. These findings may represent underlying trait abnormalities in bipolar disorder.
OBJECTIVES: The inferior frontal cortical-striatal network plays an integral role in response inhibition in normal populations. While inferior frontal cortex (IFC) impairment has been reported in mania, this study explored whether this dysfunction persists in euthymia. METHODS: Functional magnetic resonance imaging (fMRI) activation was evaluated in 32 euthymic patients with bipolar I disorder and 30 healthy subjects while performing the Go/NoGo response inhibition task. Behavioral data were collected to evaluate accuracy and response time. Within-group and between-group comparisons of activation were conducted using whole-brain analyses to probe significant group differences in neural function. RESULTS: Both groups activated bilateral IFC. However, between-group comparisons showed a significantly reduced activation in this brain region in euthymic patients with bipolar disorder compared to healthy subjects. Other frontal and basal ganglia regions involved in response inhibition were additionally significantly reduced in bipolar disorderpatients, in both the medicated and the unmedicated subgroups. No areas of greater activation were observed in bipolar disorderpatients versus healthy subjects. CONCLUSIONS:Bipolar disorderpatients, even during euthymia, have a persistent reduction in activation of brain regions involved in response inhibition, suggesting that reduced activation in the orbitofrontal cortex and striatum is not solely related to the state of mania. These findings may represent underlying trait abnormalities in bipolar disorder.
Authors: Lara C Foland-Ross; Paul M Thompson; Catherine A Sugar; Sarah K Madsen; Jim K Shen; Conor Penfold; Kyle Ahlf; Paul E Rasser; Jeffrey Fischer; Yilan Yang; Jennifer Townsend; Susan Y Bookheimer; Lori L Altshuler Journal: Am J Psychiatry Date: 2011-02-01 Impact factor: 18.112
Authors: Dina M Kronhaus; Natalia S Lawrence; Andrew M Williams; Sophia Frangou; Michael J Brammer; Steve C R Williams; Christopher M Andrew; Mary L Phillips Journal: Bipolar Disord Date: 2006-02 Impact factor: 6.744
Authors: Lori L Altshuler; Susan Y Bookheimer; Jennifer Townsend; Manuel A Proenza; Naomi Eisenberger; Fred Sabb; Jim Mintz; Mark S Cohen Journal: Biol Psychiatry Date: 2005-11-15 Impact factor: 13.382
Authors: John L Beyer; Warren D Taylor; James R MacFall; Maragatha Kuchibhatla; Martha E Payne; James M Provenzale; Frederick Cassidy; K Ranga R Krishnan Journal: Neuropsychopharmacology Date: 2005-12 Impact factor: 7.853
Authors: Lori Altshuler; Susan Bookheimer; Jennifer Townsend; Manuel A Proenza; Fred Sabb; Jim Mintz; Mark S Cohen Journal: Bipolar Disord Date: 2008-09 Impact factor: 6.744
Authors: Catherine E Hegarty; Lara C Foland-Ross; Katherine L Narr; Catherine A Sugar; James J McGough; Paul M Thompson; Lori L Altshuler Journal: Bipolar Disord Date: 2012-12 Impact factor: 6.744
Authors: Qing Zhao; Zhi Li; Jia Huang; Chao Yan; Paola Dazzan; Christos Pantelis; Eric F C Cheung; Simon S Y Lui; Raymond C K Chan Journal: Schizophr Bull Date: 2013-05-13 Impact factor: 9.306
Authors: David Pagliaccio; Jillian Lee Wiggins; Nancy E Adleman; Elizabeth Harkins; Alexa Curhan; Kenneth E Towbin; Melissa A Brotman; Daniel S Pine; Ellen Leibenluft Journal: Biol Psychiatry Date: 2016-09-16 Impact factor: 13.382
Authors: Stephen M Strakowski; Caleb M Adler; Jorge Almeida; Lori L Altshuler; Hilary P Blumberg; Kiki D Chang; Melissa P DelBello; Sophia Frangou; Andrew McIntosh; Mary L Phillips; Jessika E Sussman; Jennifer D Townsend Journal: Bipolar Disord Date: 2012-06 Impact factor: 6.744
Authors: Shantanu H Joshi; Nathalie Vizueta; Lara Foland-Ross; Jennifer D Townsend; Susan Y Bookheimer; Paul M Thompson; Katherine L Narr; Lori L Altshuler Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2016-11
Authors: Rasim Somer Diler; Anna Maria Segreti; Cecile D Ladouceur; Jorge R C Almeida; Boris Birmaher; David A Axelson; Mary L Phillips; Lisa Pan Journal: J Child Adolesc Psychopharmacol Date: 2013-04 Impact factor: 2.576
Authors: Rasim Somer Diler; Lisa A Pan; Annamaria Segreti; Cecile D Ladouceur; Erika Forbes; Soledad Romero Cela; Jorge R C Almeida; Boris Birmaher; David A Axelson; Mary L Phillips Journal: J Can Acad Child Adolesc Psychiatry Date: 2014-02